Nov 7, 2024 08:01AM
Aug 14, 2024 08:01AM
Nov 13, 2023 04:05PM
Aug 9, 2023 04:05PM
Mar 30, 2023 04:40PM
Jan 18, 2023 08:01AM
Jan 18, 2023 08:00AM NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Sep 15, 2022 08:31AM
Sep 15, 2022 08:30AM
May 6, 2022 08:00AM
Mar 15, 2022 08:00AM
Jan 28, 2022 04:31PM
Jan 28, 2022 04:30PM
Nov 15, 2021 08:00AM NeuroBo Pharmaceuticals Reports Third Quarter 2021 Financial Results
Nov 4, 2021 08:02AM
Nov 4, 2021 08:00AM
Oct 13, 2021 08:02AM
Oct 13, 2021 08:00AM
Oct 5, 2021 01:13PM
Oct 1, 2021 08:05AM
Oct 1, 2021 08:00AM NeuroBo Pharmaceuticals Announces $14 Million Registered Direct Offering
Aug 16, 2021 08:00AM
Jul 12, 2021 08:37AM
Jul 12, 2021 08:30AM
May 17, 2021 05:02PM
Apr 15, 2021 04:52PM
Mar 24, 2021 08:00AM
Mar 5, 2021 08:30AM NeuroBo Pharmaceuticals to Participate in H.C. Wainwright Global Life Sciences Conference
Mar 3, 2021 07:00AM
Jan 6, 2021 08:31AM
Jan 6, 2021 08:30AM
Nov 13, 2020 04:30PM
Sep 2, 2020 08:30AM
Aug 11, 2020 03:00PM
Jun 16, 2020 04:05PM NeuroBo Pharmaceuticals to Join Russell 3000® and Microcap® Indexes
May 26, 2020 08:37AM
May 26, 2020 08:30AM
May 20, 2020 04:29PM
Mar 30, 2020 04:30PM
Jan 10, 2020 05:00PM
Dec 30, 2019 11:08AM
Dec 30, 2019 11:08AM Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All